AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34019535 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 80
Study 32175647 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (1 mg once daily for 48 hours before surgery and 0.5 mg twice daily for 5 days after surgery)
Number of subjects: 160
Study 32175647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 34743382 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced speech envelope (EE) intervention group (n=31)
Number of subjects: 91
Study 34743382 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-enhanced stories intervention group (n=31)
Number of subjects: 91
Study 34743382 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=29)
Number of subjects: 91
Study 33783622 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rhythm control therapy (antiarrhythmic drugs or catheter ablation)
Number of subjects: 0
Study 33783622 — intervention group
Group type: COMPARATOR
Intervention: Guideline-based AF management
Number of subjects: 0
Study 35105329 — intervention group
Group type: EXPERIMENTAL
Intervention: BCD-021
Number of subjects: 357
Study 35105329 — intervention group
Group type: COMPARATOR
Intervention: Reference bevacizumab
Number of subjects: 357
Study 34259409 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion applied to ashi point, Zusanli (ST 36), Xuehai (SP 10), and Qihai (CV 6) for 30 min, 3 times a week for 8 weeks
Number of subjects: 80
Study 34259409 — intervention group
Group type: COMPARATOR
Intervention: Calcipotriol ointment (0.25 g each time, twice daily) for 8 weeks
Number of subjects: 80
Study 36203788 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous preoperative unilateral ESPB (20mL bupivacaine 0.25% bolus then 6 mL/h 0.1% for 48 hours)
Number of subjects: 60
Study 36203788 — intervention group
Group type: COMPARATOR
Intervention: Intravenous patient-controlled analgesia (PCA) morphine (0.01 mg/kg/h)
Number of subjects: 60
Study 33211799 — intervention group
Group type: EXPERIMENTAL
Intervention: Obinutuzumab
Number of subjects: 670
Study 33211799 — intervention group
Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 670
Study 33211799 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 670
Study 35449853 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve block
Number of subjects: 60
Study 35449853 — intervention group
Group type: COMPARATOR
Intervention: Adductor canal block
Number of subjects: 60
Study 35449853 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 33611557 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task gait training using a treadmill
Number of subjects: 34
Study 33611557 — intervention group
Group type: COMPARATOR
Intervention: Single-task training involving gait and cognitive task separately
Number of subjects: 34
Study 36302047 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound-guided biliary drainage (EUS-BD)
Number of subjects: 212
Study 36302047 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy-guided percutaneous transhepatic biliary drainage (PTBD)
Number of subjects: 212
Study 32767710 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated pomegranate juice (CPJ), n = 22, duration 8 weeks
Number of subjects: 44
Study 32767710 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 22)
Number of subjects: 44
Study 35323474 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown seaweed extract (500 mg/d)
Number of subjects: 56
Study 32332648 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal electrical stimulation (TVES) for 5 times
Number of subjects: 67
Study 32332648 — intervention group
Group type: COMPARATOR
Intervention: Transvaginal electrical stimulation (TVES) for 3 times with EMG-triggered neuromuscular stimulation twice
Number of subjects: 67
Study 36098600 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosanpolysulfate (PPS)
Number of subjects: 0
Study 36098600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34032715 — intervention group
Group type: EXPERIMENTAL
Intervention: Nazartinib
Number of subjects: 78
Study 34032715 — intervention group
Group type: COMPARATOR
Intervention: Other chemotherapeutic agents
Number of subjects: 78
Study 33956561 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised progressive resistance training (RT)
Number of subjects: 42
Study 33956561 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised Nordic Walking (NW)
Number of subjects: 42
Study 33956561 — intervention group
Group type: COMPARATOR
Intervention: Unsupervised home-based exercise (HBE)
Number of subjects: 42
Study 36284216 — intervention group
Group type: EXPERIMENTAL
Intervention: IMPROVEjob leadership program (participatory, interdisciplinary, multimodal intervention with two leadership workshops, a toolbox, and a 9-month implementation phase)
Number of subjects: 268
Study 36284216 — intervention group
Group type: EXPERIMENTAL
Intervention: IMPROVEjob workshops
Number of subjects: 268
Study 36284216 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 pandemic adjustments
Number of subjects: 268
Study 36284216 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting-list control)
Number of subjects: 268
Study 33694253 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of nanoencapsulated eugenol (NE)
Number of subjects: 56
Study 33694253 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 56
Study 32149391 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical group (augmented corticotomy), n = 47
Number of subjects: 30
Study 32149391 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical group, n = 13
Number of subjects: 30
Study 33461852 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with standardized JC pollen extract
Number of subjects: 69
Study 33461852 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 69
Study 32478802 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 5221
Study 32478802 — intervention group
Group type: COMPARATOR
Intervention: Initial medical therapy
Number of subjects: 5221
Study 35353915 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture with pelvic floor exercise (PFE)
Number of subjects: 137
Study 35353915 — intervention group
Group type: COMPARATOR
Intervention: Pelvic floor exercise (PFE) alone
Number of subjects: 137
Study 33567016 — intervention group
Group type: EXPERIMENTAL
Intervention: Coconut water-based solution (G1)
Number of subjects: 0
Study 33567016 — intervention group
Group type: COMPARATOR
Intervention: OPTISOL GS® (G2)
Number of subjects: 0
Study 32791322 — intervention group
Group type: EXPERIMENTAL
Intervention: AgingPLUS educational program targeting negative views of aging, low self-efficacy beliefs, and poor goal planning skills over 4 weeks with 2-hour sessions each week.
Number of subjects: 288
Study 32791322 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving a 4-week health education program.
Number of subjects: 288
Study 35093409 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocovid SupraBio 200mg and pentoxifylline 400mg orally twice daily for one year
Number of subjects: 62
Study 35093409 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 35093409 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocovid SupraBio and pentoxifylline
Number of subjects: 62
Study 34906985 — intervention group
Group type: EXPERIMENTAL
Intervention: Sending Christmas cards (intervention group)
Number of subjects: 3223
Study 34906985 — intervention group
Group type: COMPARATOR
Intervention: No Christmas card (control group)
Number of subjects: 3223
Study 36228446 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained obstetricians
Number of subjects: 91
Study 36228446 — intervention group
Group type: COMPARATOR
Intervention: Untrained obstetricians
Number of subjects: 91
Study 36228446 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 91
Study 32710157 — intervention group
Group type: EXPERIMENTAL
Intervention: High realism virtual smoking scenarios
Number of subjects: 0
Study 32710157 — intervention group
Group type: COMPARATOR
Intervention: Low realism virtual smoking scenarios
Number of subjects: 0
Study 32808164 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine
Number of subjects: 189
Study 32808164 — intervention group
Group type: COMPARATOR
Intervention: Artificial Tears (ATs)
Number of subjects: 189
Study 32808164 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine (surgery within last 3 years)
Number of subjects: 189
Study 32808164 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine (surgery 3 or more years prior)
Number of subjects: 189
Study 36395190 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued walking conditions (internal and external cues: visual, auditory, tactile)
Number of subjects: 80
Study 36395190 — intervention group
Group type: COMPARATOR
Intervention: Baseline walking without cues
Number of subjects: 80
Study 34577869 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity extracorporeal shock wave therapy (LiESWT) with 0.25 mJ/mm2 intensity, 3000 pulses, and 3 pulses/s, once weekly for 4 weeks
Number of subjects: 60
Study 34577869 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity extracorporeal shock wave therapy (LiESWT) with 0.25 mJ/mm2 intensity, 3000 pulses, and 3 pulses/s, once weekly for 8 weeks
Number of subjects: 60
Study 34577869 — intervention group
Group type: COMPARATOR
Intervention: Sham LiESWT treatment without energy transmission
Number of subjects: 60
Study 33725219 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical assessment
Number of subjects: 212
Study 33725219 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (USG) assessment
Number of subjects: 212
Study 33725219 — intervention group
Group type: COMPARATOR
Intervention: USG assessment
Number of subjects: 212
Study 33773924 — intervention group
Group type: EXPERIMENTAL
Intervention: High Pitch Dual Source Computed Tomography (HPCT)
Number of subjects: 40
Study 35618614 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsalva maneuver (20‐30 mm Hg for 10 seconds)
Number of subjects: 60
Study 35618614 — intervention group
Group type: COMPARATOR
Intervention: Control (no inspiratory pressure)
Number of subjects: 60
Study 32614619 — intervention group
Group type: EXPERIMENTAL
Intervention: Lighting from above
Number of subjects: 40
Study 32614619 — intervention group
Group type: COMPARATOR
Intervention: Anterolateral lighting
Number of subjects: 40
Study 33493544 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear Programming (LP)
Number of subjects: 32
Study 33493544 — intervention group
Group type: COMPARATOR
Intervention: Daily Undulating Programming (DUP)
Number of subjects: 32
Study 32661118 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (NIVO+IPI)
Number of subjects: 550
Study 32661118 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib (SUN)
Number of subjects: 550
Study 34965026 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyvalent mechanical bacterial lysate (PMBL) administered sublingually for 12 weeks
Number of subjects: 80
Study 34965026 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32421218 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad‐HMN patch
Number of subjects: 23
Study 32421218 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad‐LMN patch
Number of subjects: 23
Study 33835310 — intervention group
Group type: EXPERIMENTAL
Intervention: MIPS participation
Number of subjects: 30
Study 32205677 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (EX) - combination of heavy and explosive strength and sprint exercises for 20 weeks
Number of subjects: 32
Study 32205677 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (EX)
Number of subjects: 32
Study 616191717 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt-soda solution (SSS)
Number of subjects: 56
Study 616191717 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine mouthwash (CHX)
Number of subjects: 56
Study 86216967 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative intravenous infusion cholangiography and selective operative cholangiography (group 2)
Number of subjects: 187
Study 86216967 — intervention group
Group type: COMPARATOR
Intervention: Routine operative cholangiography (group 1)
Number of subjects: 187
Study 86216967 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 187
Study 34570301 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind–body program for NF
Number of subjects: 228
Study 34570301 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional distress
Number of subjects: 228
Study 32736584 — intervention group
Group type: EXPERIMENTAL
Intervention: Containers with water (522 total); 25% had immatures of Ae. aegypti (7336 total immatures).
Number of subjects: 207
Study 32736584 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized linear mixed models applied to analyze data.
Number of subjects: 207
Study 35505589 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific positioning of the shoulder in abduction, external rotation and flexion in bed, chair and during mobilization
Number of subjects: 76
Study 35505589 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (standard support scarf)
Number of subjects: 76
Study 35505589 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific positioning of the shoulder
Number of subjects: 76
Study 33831803 — intervention group
Group type: EXPERIMENTAL
Intervention: Laughter yoga (30 min, 16 sessions, twice-weekly)
Number of subjects: 68
Study 33647748 — intervention group
Group type: EXPERIMENTAL
Intervention: Regenerex (VR) coated tibial component
Number of subjects: 61
Study 33647748 — intervention group
Group type: COMPARATOR
Intervention: Porous Plasma Spray (VP) coated tibial component
Number of subjects: 61
Study 32639280 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 391
Study 32639280 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 391
Study 33146495 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week prevention program including lower limb strength and plyometric training, and joint and core stability
Number of subjects: 26
Study 33146495 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 26
Study 35815916 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin (20 mg daily) and topical tacrolimus (0.1% BD)
Number of subjects: 31
Study 35815916 — intervention group
Group type: COMPARATOR
Intervention: Finasteride (2.5 mg daily) and topical tacrolimus (0.1% BD)
Number of subjects: 31
Study 34872140 — intervention group
Group type: EXPERIMENTAL
Intervention: Infertility counseling for 6 sessions (45 minutes each, twice a week)
Number of subjects: 60
Study 34872140 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 60
Study 34387223 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaerobic Speed Reserve (ASR)
Number of subjects: 17
Study 34387223 — intervention group
Group type: COMPARATOR
Intervention: Maximal Aerobic Speed (MAS)
Number of subjects: 17
Study 34387223 — intervention group
Group type: COMPARATOR
Intervention: 30-15 Intermittent Fitness Test (30-15IFT)
Number of subjects: 17
Study 33278020 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole 10 mg daily for 5 days
Number of subjects: 24
Study 33278020 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine 5 mg daily for 5 days
Number of subjects: 24
Study 35995131 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Tri computerized measure
Number of subjects: 400
Study 35995131 — intervention group
Group type: COMPARATOR
Intervention: Traditional tests (RDS and PDRT)
Number of subjects: 400
Study 34592919 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab
Number of subjects: 462
Study 34592919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 462
Study 32564614 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume tax ($0.01/oz)
Number of subjects: 0
Study 32564614 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiered tax (<5 g of added sugar/8 oz: no tax; 5-20 g/8 oz: $0.01/oz; >20 g/8 oz: $0.02/oz)
Number of subjects: 0
Study 32564614 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute sugar content tax ($0.01 per teaspoon added sugar)
Number of subjects: 0
Study 32564614 — intervention group
Group type: COMPARATOR
Intervention: Base case of modest ongoing voluntary industry reformulation
Number of subjects: 0
Study 34543323 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe sepsis cases
Number of subjects: 350
Study 34543323 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid intake, ileus, acute kidney injury (AKI), metabolic acidosis, hypocalcemia
Number of subjects: 350
Study 33076229 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping with Cancer in the Kitchen (CCK) program, 8 weeks in-person education, culinary demonstrations, food tasting, and psychosocial support
Number of subjects: 54
Study 33076229 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping with Cancer in the Kitchen (CCK) program
Number of subjects: 54
Study 33076229 — intervention group
Group type: COMPARATOR
Intervention: CCK printed materials by mail
Number of subjects: 54
Study 35861176 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-protein calorie supplements (280 kcal/day for 6 months)
Number of subjects: 92
Study 34536639 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized cold exposure in the morning
Number of subjects: 14
Study 34536639 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized cold exposure in the evening
Number of subjects: 14
Study 34536639 — intervention group
Group type: EXPERIMENTAL
Intervention: BAT 18F-FDG uptake in the morning
Number of subjects: 14
Study 34536639 — intervention group
Group type: EXPERIMENTAL
Intervention: BAT 18F-FDG uptake in the evening
Number of subjects: 14
Study 34536639 — intervention group
Group type: EXPERIMENTAL
Intervention: BAT 18F-FDG uptake in the afternoon
Number of subjects: 14
Study 34061357 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% CSPS dentifrice
Number of subjects: 45
Study 34061357 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% arginine dentifrice
Number of subjects: 45
Study 34061357 — intervention group
Group type: COMPARATOR
Intervention: Control dentifrice
Number of subjects: 45
Study 34433510 — intervention group
Group type: EXPERIMENTAL
Intervention: CV+HIIT
Number of subjects: 46
Study 34433510 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 46
Study 34433510 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT+CV
Number of subjects: 46
Study 34433510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 34598781 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral high-dose methylprednisolone (MP)
Number of subjects: 0
Study 34598781 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral high-dose methylprednisolone (MP) administered at home
Number of subjects: 0
Study 32036109 — intervention group
Group type: EXPERIMENTAL
Intervention: Connected environment with perfect communication (fully functioning and uninterrupted supply of driving messages)
Number of subjects: 78
Study 32036109 — intervention group
Group type: EXPERIMENTAL
Intervention: Connected environment with communication delay (impaired communication)
Number of subjects: 78
Study 32036109 — intervention group
Group type: COMPARATOR
Intervention: Baseline (without driving messages)
Number of subjects: 78
Study 36209047 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg of galcanezumab (2 prefilled syringes of 120 mg)
Number of subjects: 47
Study 36209047 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg of galcanezumab with conventional preventive therapy
Number of subjects: 47
Study 36209047 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg of galcanezumab as initial preventive therapy
Number of subjects: 47
Study 36209047 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg of galcanezumab
Number of subjects: 47
Study 36209047 — intervention group
Group type: COMPARATOR
Intervention: 240 mg of galcanezumab therapy add-on conventional preventive therapy
Number of subjects: 47
Study 36209047 — intervention group
Group type: COMPARATOR
Intervention: 240 mg of galcanezumab initial therapy
Number of subjects: 47
Study 34407846 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementation dose of 3 g of vitamin C per day for 96 h
Number of subjects: 270
Study 34407846 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological dose of 10 g of vitamin C per day for 96 h
Number of subjects: 270
Study 34407846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 32898218 — intervention group
Group type: EXPERIMENTAL
Intervention: Early OGTT at 18 to 20 gestational weeks
Number of subjects: 522
Study 32898218 — intervention group
Group type: COMPARATOR
Intervention: Standard OGTT at 24 to 28 gestational weeks
Number of subjects: 522
Study 32898218 — intervention group
Group type: EXPERIMENTAL
Intervention: GDM group (early diagnosis)
Number of subjects: 522
Study 35477764 — intervention group
Group type: EXPERIMENTAL
Intervention: Group savings promotion, coaching and entrepreneurship training with a lump-sum cash grant
Number of subjects: 0
Study 35477764 — intervention group
Group type: EXPERIMENTAL
Intervention: Group savings promotion, coaching and entrepreneurship training with psychosocial interventions
Number of subjects: 0
Study 35477764 — intervention group
Group type: EXPERIMENTAL
Intervention: Group savings promotion, coaching and entrepreneurship training with both cash grant and psychosocial interventions
Number of subjects: 0
Study 35477764 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33342290 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33883001 — intervention group
Group type: EXPERIMENTAL
Intervention: Gynoclear? (active)
Number of subjects: 90
Study 33883001 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 90
Study 32199488 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin emollient
Number of subjects: 600
Study 32199488 — intervention group
Group type: EXPERIMENTAL
Intervention: Early complementary feeding
Number of subjects: 600
Study 32199488 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin emollient and early complementary feeding
Number of subjects: 600